Who Owns DRMA?

Dermata Therapeutics, Inc. — Institutional Ownership & 13F Holdings

$1.41

+0.15 (+11.90%)

Market Cap

$903K

Shares Outstanding

681,557

Institutional Holders

8

Total Inst. Value

$559K

% of Float Held

101.6%

QoQ Holder Change

+7

Institutional data as of Q1 2025

New Positions

2

Closed Positions

1

Increased

4

Decreased

1

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1ARMISTICE CAPITAL, LLC$444K411,000
2UBS Group AG$76K70,290
3GEODE CAPITAL MANAGEMENT, LLCNew$22K20,406
4JONES FINANCIAL COMPANIES LLLPNew$12K121
5WELLS FARGO & COMPANY/MN$2K2,000
6Tower Research Capital LLC (TRC)$2K1,796
7SBI Securities Co., Ltd.$1K1,000
8BANK OF AMERICA CORP /DE/$021

Biggest Buyers & Sellers This Quarter

Top Sellers

FundShares RemovedValue
WELLS FARGO & COMPANY/MN-45$2K

Related Stocks

Frequently Asked Questions

How many institutional investors hold DRMA?

As of Q1 2025, 8 institutional investors report holding DRMA (Dermata Therapeutics, Inc.) in their 13F filings.

What percentage of Dermata Therapeutics, Inc. is owned by institutions?

Institutional investors hold approximately 101.6% of Dermata Therapeutics, Inc.'s float as reported in SEC 13F filings.

Which hedge fund owns the most DRMA?

The largest institutional holder of DRMA is ARMISTICE CAPITAL, LLC with $444K in shares.

Are institutions buying or selling DRMA?

This quarter, 2 institutions opened new positions in DRMA and 1 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.